TransCode Therapeutics Price Chart
TransCode Therapeutics Volume Chart
TransCode Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.00(+0.00%)
| Open | $5.50 |
|---|---|
| Close | $5.50 |
| Low | $5.50 |
| Low Change | 0.00 (0.00%) |
| High | $5.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $550.00 |
Regular Trading Hours
+0.19(+3.75%)
| Open | $5.06 |
|---|---|
| Close | $5.25 |
| Low | $5.00 |
| Low Change | -0.06 (-1.16%) |
| High | $5.51 |
| High Change | +0.45 (+8.79%) |
| Range | $0.50 |
| Volume | 8.909K |
| Dollar Volume | $46.77K |
Premarket
*No Trades in Segment
After Hours Yesterday
-0.29(-6.04%)
| Open | $4.80 |
|---|---|
| Close | $4.51 |
| Low | $4.51 |
| Low Change | -0.29 (-6.04%) |
| High | $4.80 |
| High Change | +0.00 (+0.00%) |
| Range | $0.29 |
| Volume | 828 |
| Dollar Volume | $3.73K |
Regular Trading Hours Yesterday
+0.11(+2.27%)
| Open | $4.85 |
|---|---|
| Close | $4.96 |
| Low | $4.80 |
| Low Change | -0.05 (-1.03%) |
| High | $5.31 |
| High Change | +0.46 (+9.56%) |
| Range | $0.51 |
| Volume | 3.56K |
| Dollar Volume | $17.66K |
Premarket Yesterday
*No Trades in Segment
TransCode Therapeutics News
TransCode Therapeutics Top Trades
TransCode Therapeutics's top trade so far today returned +9.97%, while the top short trade returned -4.63%.
TransCode Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $5.44 |
|---|---|
| 10 Day Moving Average (SMA10) | $6.83 |
| 20 Day Moving Average (SMA20) | $7.63 |
| 50 Day Moving Average (SMA50) | $6.28 |
| 100 Day Moving Average (SMA100) | $7.44 |
| 200 Day Moving Average (SMA200) | $8.65 |
TransCode Therapeutics Statistics
| Average Volume (30 Days) | 26.98K |
|---|---|
| P/E Ratio (Current) | -.12 |
| EPS (Current) | -$41.28 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$21.40M |
| Cash Ratio | 2.39 |
| Current Ratio | 3.11 |
| Quick Ratio | 3.11 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$7.59M |
| EV to EBITDA | 0.23 |
| EV to Sales | — |
| Price to Book | 4.20 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.28% |
| Return on Equity | -34.92% |
TransCode Therapeutics Stock Splits
There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.
| Date | Type | Ratio |
|---|---|---|
| May 15, 2025 | Reverse | 28:1 |
| Dec 4, 2024 | Reverse | 33:1 |
| Jan 16, 2024 | Reverse | 40:1 |
| May 23, 2023 | Reverse | 20:1 |
TransCode Therapeutics Dividends
There have been no dividends for TransCode Therapeutics (RNAZ).